How should we manage infants at risk for group B streptococcal disease?

MOspace/Manakin Repository

Breadcrumbs Navigation

How should we manage infants at risk for group B streptococcal disease?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/2944

[+] show full item record


Title: How should we manage infants at risk for group B streptococcal disease?
Author: Carlough, Martha C.; Crowell, Karen
Keywords: intrapartum antibiotic prophylaxis
risk stratification
chorioamnionitis
Date: 2003-05
Publisher: Family Physicians Inquiries Network
Citation: Journal of Family Practice, 52(5) 2003: 406+.
Abstract: Asymptomatic term infants whose mothers received adequate intrapartum antibiotic prophylaxis (defined as intravenous penicillin or ampicillin at least 4 hours before delivery) for group B streptococcal disease do not need work-up or treatment (strength of recommendation [SOR]: B, based on retrospective, population-based study). These infants should be observed for 48 hours, but may be discharged after 24 hours in circumstances where close follow-up is available (SOR: D, based on expert opinion). Symptomatic infants, premature infants (gestational age <35 weeks) of mothers who did not receive prophylaxis, and infants whose mothers had chorioamnionitis should receive a full evaluation (complete blood count, blood culture, and chest x-ray with or without a lumbar puncture) and an initial empiric antibiotic treatment with ampicillin or penicillin and gentamycin. If a term infant is not symptomatic and maternal antibiotic prophylaxis was not adequate, opinions differ as to whether to perform limited evaluation with empiric treatment or close observation (SOR: D, based on expert opinion).
URI: http://hdl.handle.net/10355/2944

This item appears in the following Collection(s)

[+] show full item record